These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1183664)

  • 1. [Immunoglobulins IgG, IgA, IgM, IgD and IgE in porphyria cutanea tarda].
    Resl V; Sach J; Zavázal V; Nozicková M; Matĕja F
    Dermatol Monatsschr; 1975 May; 161(5):370-3. PubMed ID: 1183664
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoglobulins in sera of patients with porphyria cutanea tarda.
    Kordac V; Fucíková T
    Acta Hepatogastroenterol (Stuttg); 1978 Feb; 25(1):20-2. PubMed ID: 636736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on human immunoglobulins I. Production of monospecific antibody to human IgG, IgA, IgM and IgD.
    Harisdangkul V
    J Med Assoc Thai; 1977 Jun; 60(6):259-66. PubMed ID: 894156
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunochemical parameters and blood-letting therapy in porphyria cutanea tarda (author's transl)].
    Schwartze G; Kühn G
    Dermatol Monatsschr; 1980 Jan; 166(1):19-23. PubMed ID: 7398963
    [No Abstract]   [Full Text] [Related]  

  • 5. [Investigations of the T and B cells and the hemopexin-carrying lymphocytes in cases of porphyria cutanea tarda (author's transl)].
    Simon N; Husz S; Dobozy A; Hunyadi J
    Arch Dermatol Res (1975); 1976 Apr; 255(2):149-56. PubMed ID: 1084129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistological investigation of skin from the insolation zone in patients with porphyria cutanea tarda (author's transl)].
    Vlasín Z; Kratochvíl F
    Cesk Dermatol; 1977 Jan; 52(1):52-6. PubMed ID: 322873
    [No Abstract]   [Full Text] [Related]  

  • 7. [HLA antigen distribution and porphyria cutanea tarda--a contribution on the problem of the association of HLA with metabolic diseases].
    Gebhardt B; Köstler E; Seebacher C
    Dermatol Monatsschr; 1984; 170(8):506-10. PubMed ID: 6479408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological aspects of porphyria cutanea tarda].
    Köstler E; Seebacher C; Bässler E; Stölzel U; Pätzold K
    Dermatol Monatsschr; 1983; 169(8):498-503. PubMed ID: 6605264
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunopathology of porphyria cutanea tarda].
    Bidrat MS
    Vestn Dermatol Venerol; 1982 Jul; (7):19-23. PubMed ID: 7136251
    [No Abstract]   [Full Text] [Related]  

  • 10. [Occurrence of circulating autoantibodies in porphyria cutanea tarda].
    Köstler E; Storz H; Seebacher C
    Dermatol Monatsschr; 1985; 171(4):236-9. PubMed ID: 3891435
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of phototoxicity in porphyria cutanea tarda and erythropoietic protoporphyria.
    Lim HW
    Immunol Ser; 1989; 46():671-85. PubMed ID: 2488874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease.
    Baravalle E; Prieto J
    Gastroenterology; 1983 Jun; 84(6):1483-91. PubMed ID: 6840477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Australia antigen and porphyria cutanea tarda].
    Bolck F; Barth J; Vetter O
    Z Gesamte Inn Med; 1975 Dec; 30(23):760-3. PubMed ID: 1224741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycological and serological studies of patients with porphyria cutanea tarda].
    Farkas B; Hunyadi J; Simon N
    Mykosen; 1982 Nov; 25(11):606-17. PubMed ID: 6757745
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies to the Borrelia burgdorferi flagellum in patients with scleroderma, granuloma annulare and porphyria cutanea tarda.
    Halkier-Sørensen L; Kragballe K; Hansen K
    Acta Derm Venereol; 1989; 69(2):116-9. PubMed ID: 2564227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of porphyria cutanea tarda sclerodermiformis].
    Olszewska Z; Woźniak L; Dudek H
    Przegl Dermatol; 1971; 58(1):59-64. PubMed ID: 5554741
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
    Bidrat MS
    Vestn Dermatol Venerol; 1984 Oct; (10):20-3. PubMed ID: 6516569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of autoantibodies in patients with porphyria cutanea tarda].
    Plechistova LA; Vybornov VA
    Vestn Dermatol Venerol; 1974 Jun; 0(6):32-6. PubMed ID: 4278569
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic discoid erythematosus and porphyria cutanea tarda].
    Malina L; Jíra M
    Cas Lek Cesk; 1987 Dec; 126(52):1620-3. PubMed ID: 3442789
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA and porphyria cutanea tarda.
    Llorente L; Enríquez de Salamanca R; Campillo F; Peña ML
    Arch Dermatol Res; 1980; 269(2):209-10. PubMed ID: 7458411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.